Back to News
Market Impact: 0.2

Validea Detailed Fundamental Analysis

ELVNDAQ
Company FundamentalsAnalyst InsightsDerivatives & VolatilityHealthcare & BiotechInvestor Sentiment & Positioning
Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates Elevance Health (ELV) scores 68% using the Pim van Vliet Multi-Factor Investor model, which prioritizes low volatility, strong momentum, and high net payout yields. While ELV passed market cap and standard deviation criteria, it received a 'Neutral' rating for both momentum and net payout yield, ultimately resulting in a 'FAIL' on its final rank within this quantitative strategy. This score falls below the 80% threshold typically indicating interest, suggesting ELV does not align strongly with the model's criteria for investment.

Analysis

According to a Validea fundamental report, Elevance Health (ELV) does not align with the criteria of the Pim van Vliet Multi-Factor Investor model, a strategy focused on low-volatility stocks with strong momentum and high net payout yields. The company scored 68%, falling below the 80% threshold that typically signals investment interest from the model. While ELV passed the model's screens for large market capitalization and low standard deviation, indicating favorable defensive characteristics, it failed to demonstrate strength in key return-driving factors. Specifically, ELV received 'Neutral' ratings for both its 'Twelve Minus One Momentum' and 'Net Payout Yield'. This combination of meeting risk-based criteria but faltering on momentum and shareholder return metrics ultimately led to a 'FAIL' on its final rank within this quantitative framework.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo